Performance of Field Evaluated Malaria Rapid Diagnostic Tests
By LabMedica International staff writers Posted on 22 Sep 2016 |

Image: The CareStart Malaria rapid diagnostic tests diagnose malaria infection from whole blood of patients in 20 minutes (Photo courtesy of Access Bio).
The introduction of malaria rapid diagnostic tests (RDTs) has enhanced quick examination of blood samples from suspected malaria patients; however, it is not clear which RDT is the most appropriate in different endemic areas with mono and mixed infections of different parasites.
Regardless of the setting, RDTs require minimal operator training, and yield highly reproducible test interpretations. RDT results are normally rapidly available when the physician is actively managing patients as the test can be completed in less than 20 minutes. They do not require any instrumentation, electricity, special laboratories, or water and these kits are generally cost-beneficial.
Scientists at the Kenya Medical Research Institute (Nairobi, Kenya) and their colleagues evaluated commercial RDTs for malaria on 500 study participants. The study participants included 290 (58%) children younger than 12 years and the other 210 ranged in age from 13 to 64 year. The 181 male participants were a minority of participants while the majority of the participants were the 319 females. The 196 adult women who were not pregnant comprised 39% of the female population.
The team assessed the performance of BinaxNow, SD Bioline, CareStart Malaria, and First Response. These RDTs were compared to thin and thick blood film microscopy and real time polymerase chain reaction (PCR). Amplification and real-time measurements was performed in the AB 7500 analytical PCR system from Applied Biosystems.
Of the 500 participants recruited, 33% were malaria positive by microscopy while 51.2 % were positive by PCR. Compared to microscopy, the sensitivity of the RDTs to detect malaria parasites was 90.3% to 94.8 %, the specificity was 73.3% to 79.3%, the positive predictive value was 62.2% to 68.8%, and the negative predictive value was 94.3% to 96.8%. Compared to PCR, the sensitivity of the RDTs to detect malaria parasites was 71.1% to 75.4%, the specificity was 80.3% to 84.4 %. The RDTs had a moderate measure of agreement with both microscopy of more than 80.1 % and PCR of more than 77.6 %.
The authors concluded that rapid diagnostic tests can be applied in a number of settings with a great potential for impact on public health where they can significantly improve the quality of malaria case management in areas where expert microscopy or PCR methods are not available. This study demonstrated that CareStart, SD Bioline, BinaxNow, and First Response RDTs performed reasonably well in this endemic region for the detection of Plasmodium falciparum. The study was published on September 7, 2016, in the Malaria Journal.
Related Links:
Kenya Medical Research Institute
Regardless of the setting, RDTs require minimal operator training, and yield highly reproducible test interpretations. RDT results are normally rapidly available when the physician is actively managing patients as the test can be completed in less than 20 minutes. They do not require any instrumentation, electricity, special laboratories, or water and these kits are generally cost-beneficial.
Scientists at the Kenya Medical Research Institute (Nairobi, Kenya) and their colleagues evaluated commercial RDTs for malaria on 500 study participants. The study participants included 290 (58%) children younger than 12 years and the other 210 ranged in age from 13 to 64 year. The 181 male participants were a minority of participants while the majority of the participants were the 319 females. The 196 adult women who were not pregnant comprised 39% of the female population.
The team assessed the performance of BinaxNow, SD Bioline, CareStart Malaria, and First Response. These RDTs were compared to thin and thick blood film microscopy and real time polymerase chain reaction (PCR). Amplification and real-time measurements was performed in the AB 7500 analytical PCR system from Applied Biosystems.
Of the 500 participants recruited, 33% were malaria positive by microscopy while 51.2 % were positive by PCR. Compared to microscopy, the sensitivity of the RDTs to detect malaria parasites was 90.3% to 94.8 %, the specificity was 73.3% to 79.3%, the positive predictive value was 62.2% to 68.8%, and the negative predictive value was 94.3% to 96.8%. Compared to PCR, the sensitivity of the RDTs to detect malaria parasites was 71.1% to 75.4%, the specificity was 80.3% to 84.4 %. The RDTs had a moderate measure of agreement with both microscopy of more than 80.1 % and PCR of more than 77.6 %.
The authors concluded that rapid diagnostic tests can be applied in a number of settings with a great potential for impact on public health where they can significantly improve the quality of malaria case management in areas where expert microscopy or PCR methods are not available. This study demonstrated that CareStart, SD Bioline, BinaxNow, and First Response RDTs performed reasonably well in this endemic region for the detection of Plasmodium falciparum. The study was published on September 7, 2016, in the Malaria Journal.
Related Links:
Kenya Medical Research Institute
Latest Microbiology News
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
- Culture-Free Platform Rapidly Identifies Blood Stream Infections
- POC PCR Test Rapidly Detects Bacterial Meningitis Directly at Point of Sample Collection
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more
New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
Drug-induced kidney injury, also known as nephrotoxicity, is a prevalent issue in clinical practice, occurring when specific medications at certain doses cause damage to the kidneys. Nephrotoxicity can... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
Tecan Group (Männedorf, Switzerland) has entered into an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS (Codolet, France), a subsidiary of the... Read more